Brawley to receive 2019 AMA Distinguished Service Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Otis Webb Brawley was named recipient of the 2019 AMA Distinguished Service Award by the American Medical Association board of trustees.

The award is the highest honor bestowed by AMA for “meritorious service in the science and art of medicine.”

Brawley is the Bloomberg Distinguished Professor of Oncology and Epidemiology at John Hopkins University Schools of Medicine and Public Health. He is a Fellow of the American Society of Clinical Oncology, a Fellow of the American College of Epidemiology, and a Master of the American College of Physicians. He is also an elected member of the National Academy of Medicine.

He is a former chief medical and scientific officer at the American Cancer Society, where he was involved in cancer prevention, early detection, and quality treatment through cancer research and education. He continues to champion efforts to decrease smoking, improve diet, detect cancer at the earliest stage, and provide the critical support cancer patients need.

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login